FAIM
DXCM icon

Financial Advocates Investment Management’s DexCom DXCM Stock Holding History

Financial Advocates Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,112
Closed -$417K – 661
2025
Q1 		$417K Sell
6,112
-6
-0.1% -$490 0.03% 467
2024
Q4 		$476K Buy
+6,118
New +$453K 0.03% 462
2023
Q4 		– Sell
-2,636
Closed -$246K – 740
2023
Q3 		$246K Sell
2,636
-157
-6% -$17.7K 0.02% 587
2023
Q2 		$359K Buy
2,793
+168
+6% +$20.3K 0.03% 473
2023
Q1 		$305K Sell
2,625
-5,981
-69% -$670K 0.02% 552
2022
Q4 		$975K Buy
8,606
+3,717
+76% +$408K 0.07% 295
2022
Q3 		$268K Buy
4,889
+1,376
+39% +$117K 0.02% 585
2022
Q2 		$262K Buy
+3,513
New +$321K 0.02% 545
2022
Q1 		– Sell
-10,084
Closed -$1.3M – 752
2021
Q4 		$1.3M Buy
+10,084
New +$1.45M 0.08% 280
2020
Q4 		– Sell
-3,088
Closed -$318K – 722
2020
Q3 		$318K Buy
+3,088
New +$323K 0.03% 466

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Financial Advocates Investment Management's DXCM Position: Q2 2025 in Review

Financial Advocates Investment Management sold out of DexCom (DXCM) in Q2 2025, closing a stake of 6,112 shares — an estimated $417K sold.

Financial Advocates Investment Management first reported a position in DXCM in Q3 2020 and held it in 10 quarters. The position peaked at $1.3M in Q4 2021. 940 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

  • Financial Advocates Investment Management reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
  • Financial Advocates Investment Management sold 6,112 DexCom shares in Q2 2025, an estimated $417K.
  • Financial Advocates Investment Management first reported a position in DexCom in Q3 2020 and held it in 10 quarters.
  • Financial Advocates Investment Management's DexCom position peaked at $1.3M in Q4 2021.
  • 940 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on Financial Advocates Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.